Publications by authors named "Ross Jennens"

Claim this Profile
R
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.
Matthew Loft, Vanessa Wong, Suzanne Kosmider, Rachel Wong, Jeremy Shapiro, Ross Jennens

Intern Med J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.
Meera R Agar, Anna K Nowak, Elizabeth J Hovey, Elizabeth H Barnes, John Simes, Ross Jennens

BMJ Support Palliat Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Hao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, Sonia Yip, Eng-Siew Koh, Ross Jennens

Neurooncol Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.
Jason D Lickliter, Jeremy Ruben, Ganessan Kichenadasse, Ross Jennens, Cecelia Gzell

Cancer Res Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Heather Thorne, Lisa Devereux, Jason Li, Kathryn Alsop, Liz Christie, Ross Jennens

Histopathology· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
Marina C Garassino, Shirish Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Ross R Jennens

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Ross R Jennens

J Immunother Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
Chia Yuen Chong, Azim Jalali, Hui Li Wong, Matthew Loft, Rachel Wong, Ross Jennens

Asia Pac J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.
Jordan Santucci, Mark Tacey, Benjamin Thomson, Michael Michael, Rachel Wong, Ross Jennens

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Hedy L Kindler, Silvia Novello, Alessandra Bearz, Giovanni L Ceresoli, Joachim G J V Aerts, Ross Jennens

Lancet Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.
Luke S McLean, Wasek Faisal, Sagun Parakh, Steven C Kao, Craig R Lewis, Ross R Jennens

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer.
Zarique Z Akanda, Paul J Neeson, Thomas John, Stephen Barnett, Gerard G Hanna, Ross Jennens

Transl Lung Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer.
Evangeline Samuel, Cherie Chiang, Ross Jennens, David Faulkner, Prudence A Francis

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Shirish Gadgeel, Delvys Rodríguez-Abreu, Giovanna Speranza, Emilio Esteban, Enriqueta Felip, Ross R Jennens

J Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.
Shehara Mendis, Sophie Beck, Belinda Lee, Margaret Lee, Rachel Wong, Ross Jennens

Asia Pac J Clin Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Ross R Jennens

N Engl J Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
Lavinia Tan, Marliese Alexander, Ann Officer, Michael MacManus, Linda Mileshkin, Ross Jennens

Intern Med J· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.
Belinda Lee, Hui-Li Wong, Mark Tacey, Jeanne Tie, Rachel Wong, Ross Jennens

Asia Pac J Clin Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
Hui-Li Wong, Belinda Lee, Kathryn Field, Anna Lomax, Mark Tacey, Ross Jennens

Clin Colorectal Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Melanoma.
Eshini Perera, Neiraja Gnaneswaran, Ross Jennens, Rodney Sinclair

Healthcare (Basel)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patients.
Peter Gibbs, Tracey J Brown, Raymond Ng, Ross Jennens, Edith Cinc

Chemotherapy· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?
Kathryn M Field, Suzanne Kosmider, Michael Jefford, Ross Jennens, Michael Green

J Oncol Pract· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey.
Kathryn M Field, Suzanne Kosmider, Michael Jefford, Michael Michael, Ross Jennens

J Oncol Pract· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of two-weekly temozolomide in patients with high-grade gliomas.
Shirley Wong, Mark A Rosenthal, Anthony Dowling, Ross Jennens, Anne-Marie Woods

J Clin Neurosci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer.
Ross R Jennens, Richard de Boer, Louis Irving, David L Ball, Mark A Rosenthal

Chest· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis